Jim Sargent

Founder and Managing Partner
20+ years of life science experience
Pfizer, Boston Scientific United States and Boston Scientific Asia

Jim was responsible for penetrating new countries and integrating acquired companies into the US market. During this time, Jim also served as the Chairman of the Medical Devices Committee for the Korean delegation of AMCHAM.

From this cultural and commercial foundation, Jim formed RQR Partners, focused on developing and evaluating commercial strategy and investment decisions for new innovations and technologies from across the globe.

Jim’s main focus is our corporate development in international markets. Working directly with our foreign government partners and their respective life science ecosystems, he identifies investment needs and opportunities for their startups as they assess commercial strategy for the United States.

Eric Halvorson

Partner
30 years life science experience
Boston Scientific, Smith and Nephew, Olympus and Coloplast

Eric has mastered the dynamics of the global life science market place, and has a great appreciation for cultural nuances and norms. He started his career with Boston Scientific and was an inaugural member of the urology business unit. Having also lived in Europe during his 12 years at BSC, Eric experienced firsthand the differences in the healthcare markets. Later, Eric took on General Management roles at Olympus (Japanese company) and Coloplast (Danish company).

During his 30 years, he built fast growing companies, turned around underperforming businesses. As an executive for the strategics, he led several successful acquisitions, with a keen eye toward the commercial viability and strategic fit.

As a past and current board member for numerous Medical Device and Digital Health companies, along with Physician Specialty Societies, he brings to RQR Partners in-depth expertise in the field, real life operating experience, and years of customer facing interactions. Eric has a strong track record of building new businesses, and making strategic acquisitions. He has successfully executed and integrated acquisitions into strategics ranging from $10M to $1.9B in size.

Patrick Lichter

Partner
25+ years working in the medical device industry
Koronis Biomedical Technologies

Patrick is our lead technical development professional, with a lens toward assessing early stage Biomedical Engineering technologies and the potential for development through the R&D stages. He is skilled in Engineering Management, Medical Devices, and Strategic Planning.

Along with leading his own company through all of the growth stages towards final strategic acquisition (QRS Diagnostic, 2015), Patrick has also participated in multiple start-ups and successfully submitted and executed on NIH-funded grants from Small Business Innovative Research (SBIR).

Tony Hessburg

Partner
25+ years of Marketing experience in the US and Europe
ELEVEN

Tony has deep experience working with European companies on developing and managing US marketing efforts, channel management and strategy to attract early-stage life science companies and foreign government entities investing in life science.

Founder of a marketing and technology services provider, Tony brings forward-thinking strategy, commercialization, marketing, branding, digital transformation and technology implementation for clients ranging from leading global brands to start-ups. He has comprehensive experience working with European companies to develop US marketing efforts and channel strategy.

Clients include: Allaction Sports Group, Blattner Energy, Aveda, Crestliner, Clarins, Coloplast, Deluxe, Eyemart Express, HOYA, Laura Mercier, LensCrafters, M Health C.O.R.E., Nyakio, Ottobock, Palmer Snowboards, Pearle Vision, Polaris, Power Plate, Ranger Boats, Ray Ban, Red Bull, Trek, Victory Motorcycles, Unicef and Vision-Ease.

Dr. Arjun Sharma

M.D., FACC, FRCPC
Advisory Partner
25+ years of life science experience

Dr. Sharma is trained as a cardiac electrophysiologist, and has 25 years of experience in academic (Canada) and private practice medicine (California). He has published over 170 medical articles and lectured internationally. During that time Dr. Sharma was an external consultant, medical board member, and investigator to biomedical companies (MDT, SJM, Guidant, ELA, Telectronics). Dr. Sharma was the Vice President of Medical Safety at Boston Scientific Corporation CRM, where he worked for 9 years. In this capacity Dr. Sharma worked closely with the Quality and Regulatory groups to monitor fielded products, participated in FDA meetings, managed an external Boston Scientific Safety Board, reviewed the CRM Clinical trials, dealt with specific clinical issues, and monitoring safety in trials. He worked with R&D to develop new algorithms for leadless systems, test new systems in the animal lab, address known and potential product issues, and Dr. Sharma is co-inventor on several patents. He was in the acquisition teams for the Atritech (200 million) and Cameron Medical (1.3 billion) purchases by BSX, and participated in several small company technology assessments.

Since leaving Boston Scientific Dr. Sharma has worked with startup companies in developing new products: Medicool- a Mayo Venture of cooling for arrhythmia treatment; Cardialen- novel low voltage defibrillation; Cyberheart- A stereotactic robotic radio-surgical therapy for cardiac arrhythmia which was sold to Varian. Currently, he consults with VivaQuant- a wearable monitor with patented high accuracy with improved data compression; and RQR Partners.